Skip to main content
Caplight Logo









Remora Biotech

Remora Biotech

Private
EpalingesHealthcare & Life Scienceshttps://www.remora-biotech.ch/

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Remora Biotech is a venture capital and venture builder firm that founds, finances, and develops early-stage biotherapy companies focusing on immunotherapy, vectorized therapies, and cell and gene platforms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

venture builderbiotherapy company creationstartup studioasset-centric developmentbiotech incubatortherapeutic developmentpreclinical developmentstrategic acquisitionimmunotherapycell and gene therapytranslational sciencevectorized therapiestargeted radiopharmaceuticalsregenerative biotherapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Remora Biotech Comparables

Compare Remora Biotech with similar companies based on industry and business-model similarity.

Remora Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Argobio
83%
AQYLA BioVentures
79%
Apollo Health Ventures
78%

Remora Biotech Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Jean-Marc Le Doussal

Founder CEO

Founding Team

Richard Groenendijk

Managing Partner - CFO IR

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors increased 356% MoM.

  • Jan 6, 2026

    Monthly visitors increased 34% MoM, reaching 709.

Remora Biotech Filings

Explore SEC and related filing metadata, where available.

Remora Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Remora Biotech's valuation, stock price, and market status.

Is Remora Biotech a public or private company?

Remora Biotech is a private company.

What is the current stock price of Remora Biotech?

Remora Biotech is a private company with no public stock price. No recent secondary market data is available.

How much is Remora Biotech worth (valuation)?

Valuation information for Remora Biotech is not publicly available.

Can I buy Remora Biotech stock?

Remora Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Remora Biotech's last funding round?

Funding round information for Remora Biotech is not publicly available.

Who are the main investors in Remora Biotech?

Investor information for Remora Biotech is not publicly disclosed.

Will Remora Biotech IPO soon?

No public IPO plans have been announced for Remora Biotech.

How can I track Remora Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Remora Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEpalinges
Employee Range14
Year Founded2009
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?